Nuclear magnetic resonance-based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation: results from PROSPER and FINRISK 1997

Author(s):
Delles, C.; Rankin, N.J.; Boachie, C.; McConnachie, A.; Ford, I.; Kangas, A.; Soininen, P.; Trompet, S.; Mooijaart, S.P.; Jukema, J.W. (0000-0002-3246-8359); Zannad, F.; Ala-Korpela, M.; Salomaa, V.; Havulinna, A.S.; Welsh, P.; Wurtz, P.; Sattar, N.
Published
2018
Publication type
Article / Letter to editor
MetabolomicsAdvanced lipoprotein profilingHeart failurePROSPERPhenylalanineFINRISK
Date issued
2018-04-30
Language
English
Is part of
European Journal of Heart Failure (2018), Vol. 20, no. 4, p. 663-673
hdl
1887/86657
doi
10.1002/ejhf.1076